Rosetta Genomics Ltd. Proceeds from Issuance Initial Public Offering
Rosetta Genomics Ltd. reported Proceeds from Issuance Initial Public Offering of $3.29 million for the 12-month period ending 2016-12-31, per its 6-K filed 2017-10-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2017-10-10
| Period end | Proceeds from Issuance Initial Public Offering 0 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|
| 2016-12-31 | $3.29M 6-K · filed 2017-10-10 | |
| 2012-08-29 | $3.84M 20-F · filed 2013-03-22 | |
| 2012-08-08 | $24.99M 20-F · filed 2013-03-22 |